drugset / Trial / NCT05930002
Role of Ivermectin and Colchicine in Treatment of COVID-19: Randomized Controlled Clinical Trial
RandomizedParallel-groupSingle-blindTreatment
Summary
Corona virus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), a new corona virus that emerged in Wuhan, China, in December 2019. It spread rapidly throughout the world causing great mortality. Till date, there is no specific treatment for COVID-19; Ivermectin and colchicine were proposed as therapeutic options for treatment of COVID-19. Our randomised controlled clinical trial aims to assess the effectiveness of ivermectin and colchicine for treating COVID-19.
Timeline
- Start
- 2021-07-21
- Primary completion
- 2022-09-09
- Completion
- 2022-12-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Colchicine | Small molecule | 0.5 mg | — |
| Comparator | Ivermectin | Small molecule | 0.2 mg/kg | Oral |
| Comparator | Cholecalciferol | Other / unclassified | 2000 iu | — |
| Comparator | Cholecalciferol | Other / unclassified | 4000 iu | — |
| Comparator | Vitamin C | Other / unclassified | 500 mg | — |
| Comparator | Zinc Sulfate | Unknown | 75 mg | — |